Literatur
-
1
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) .
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
Lancet.
1986;
1
397-402
-
2
The European Myocardial Infarction Project Group .
Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.
N Engl J Med.
1993;
329
383-389
-
3
The European Myocardial Infarction Project Group .
Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.
N Engl J Med.
1993;
329
383-389
-
4
Assessment of the Safety and Efficacy of a New Thrombolytic Investigators .
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
Lancet.
1999;
354
716-722
-
5 The World Health Report 2003 Statistical Annex. Ref Type: Report 2003
-
6 Statistik NAW 2505 1995 - 2000. Ref Type: Internet Communication http://www.charite.de/rv/nephro/Notruf/nawstatist.html 2004
-
7
Andersen H R, Nielsen T T, Rasmussen K. et al .
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
N Engl J Med.
2003;
349
733-742
-
8
Bonnefoy E, Steg P G, Chabaud S. et al .
Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial.
Eur Heart J.
2005;
Apr 19
-
9
Collins R, Peto R, Baigent C. et al .
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
N Engl J Med.
1997;
336
847-860
-
10
Danchin N, Blanchard D, Steg P G. et al .
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
Circulation.
2004;
110
1909-1915
-
11
Danchin N, Vaur L, Genes N. et al .
Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the „real world”: one-year results from a nationwide French survey.
Circulation.
1999;
99
2639-2644
-
12
De Luca G, van’t Hof A W, de Boer M J. et al .
Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.
Eur Heart J.
2004;
25
1009-1013
-
13
Hamm C W.
Guidelines: Acute coronary syndrome. (ACS) II: Acute coronary syndrome with ST-elevation.
Z Kardiol.
2004;
93
324-341
-
14
Hanania G, Cambou J P, Gueret P. et al .
Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry.
Heart.
2004;
90
1404-1410
-
15
Hudson M P, Granger C B, Topol E J. et al .
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Circulation.
2001;
104
1229-1235
-
16
Kastrati A, Mehilli J, Nekolla S. et al .
A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
J Am Coll Cardiol.
2004;
43
734-741
-
17
Morrison L J, Verbeek P R, McDonald A C. et al .
Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.
JAMA.
2000;
283
2686-2692
-
18
Naghavi M, Libby P, Falk E. et al .
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Circulation.
2003;
108
1772-1778
-
19
Raitt M H, Maynard C, Wagner G S. et al .
Relation between symptom duration before thrombolytic therapy and final myocardial infarct size.
Circulation.
1996;
93
48-53
-
20
Rawles J.
Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).
J Am Coll Cardiol.
1994;
23
1-5
-
21
Shufelt K A, Paradiso-Hardy F L, Papastergiou J. et al .
High mortality with ST elevation myocardial infarction in a nontrial setting.
Can J Cardiol.
2004;
20
1455-1459
-
22
Steg P G, Bonnefoy E, Chabaud S. et al .
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
Circulation.
2003;
108
2851-2856
-
23
Tanswell P, Modi N, Combs D. et al .
Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.
Clin Pharmacokinet.
2002;
41
1229-1245
-
24
Van de Werf F, Ardissino D, Betriu A. et al .
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
Eur Heart J.
2003;
24
28-66
-
25
Weaver W D, Cerqueira M, Hallstrom A P. et al .
Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial.
JAMA.
1993;
270
1211-1216
-
26
Werner G S.
Optimale Lysestrategien bei akutem Herzinfarkt: Trotzdem perkutane Koronarintervention (PCI)?.
Dtsch Med Wochenschr.
2003;
128
2149-2152
-
27
Widimsky P, Budesinsky T, Vorac D. et al .
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2.
Eur Heart J.
2003;
24
94 SS>-104
Priv.-Doz. Dr. med. Stephen Schröder
Medizinische Universitätsklinik, Innere Medizin III
Otfried-Müller-Straße 10
72076 Tübingen
Telefon: 07071/2982711 (Pforte)
Fax: 07071/293169
eMail: stephen.schroeder@med.uni-tuebingen.de
